Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cellular Dynamics down in trading debut

Cellular Dynamics International Inc. (NASDAQ:ICEL) fell $2.50 (21%) to $9.50

Read the full 102 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE